Trials / Completed
CompletedNCT00799708
A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)
A Randomized, Double-Blind, Placebo-Controlled Parallel Study to Evaluate the Effects of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- Female
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
This study will develop a model for the assessment of successful activation/engagement of estrogen receptor beta using salivary biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Comparator: placebo | placebo capsule once daily for 7 days. |
| DRUG | Comparator: Estrace | Estrace 0.5 mg or 2 mg tablets once daily for 7 days. |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2008-12-01
- Last updated
- 2016-03-16
- Results posted
- 2010-07-29
Source: ClinicalTrials.gov record NCT00799708. Inclusion in this directory is not an endorsement.